C-Met Modulators and Methods of Use
US-2015376133-A1 · Dec 31, 2015 · US
US10155725B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10155725-B2 |
| Application number | US-201514981847-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 28, 2015 |
| Priority date | Nov 20, 2012 |
| Publication date | Dec 18, 2018 |
| Grant date | Dec 18, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to novel anthelmintic compounds of formula (I) below: wherein Y and Z are independently a bicyclic carbocyclic or a bicyclic heterocyclic group, or one of Y or Z is a bicyclic carbocyclic or a bicyclic heterocyclic group and the other of Y or Z is alkyl, alkenyl, alkynyl, cycloalkyl, phenyl, heterocyclyl or heteroaryl, and variables X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , X 7 and X 8 are as defined herein. The invention also provides for veterinary compositions comprising the anthelmintic compounds of the invention, and their uses for the treatment and prevention of parasitic infections in animals.
Opening claim text (preview).
What is claimed is: 1. An anthelmintic compound of formula (IA-2): wherein Y is a bicyclic carbocyclic or a bicyclic heterocyclic group selected from the group consisting of naphthyl, indolyl, benzothiazolyl, benzoxazolyl, benzodioxolyl, benzothienyl, quinuclidinyl, quinolinyl, tetrahydroisoquinolinyl, isoquinolinyl, benzimidazolyl, indolizinyl, benzofuranyl, dihydrobenzofuranyl, chromonyl, coumarinyl, benzopyranyl, cinnolinyl, quinoxalinyl, indazolyl, pyrrolopyridyl, furopyridinyl, dihydroisoindolyl, dihydroquinazolinyl and tetrahydroquinolinyl optionally substituted by one or more of halogen, nitro, cyano, hydroxy, hydroxyalkyl, amino, alkylamino, dialkylamino, aminoalkyl, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio, SF 5 , haloalkylthio, alkylsulfinyl, haloalkylsulfinyl, alkyl sulfonyl or haloalkylsulfonyl; Z is phenyl optionally substituted with one or more halogen, nitro, cyano, or haloalkyl; X 1 is a bond, X 8 is —O—, or —NH—, which is optionally substituted with alkyl; Ring A is L1: W is O or S; R 2 and R 3 are independently hydrogen or alkyl; n is 1, 2 or 3; and r is 0 to 5. 2. A composition for the treatment of a parasitic infection or infestation in an animal, comprising an effective amount of at least one anthelmintic compound of claim 1 in combination with a pharmaceutically acceptable carrier. 3. The composition of claim 2 , wherein the composition comprises an additional parasiticidal active agent. 4. A method for the treatment of a parasitic infection or infestation in an animal, comprising administering an effective amount of the anthelmintic compound of claim 1 to the animal. 5. The compound of claim 1 , wherein X 8 is —O—, —NH— or —N(CH 3 )—. 6. The compound of claim 5 , wherein: R 2 and R 3 are independently hydrogen or C 1 -C 3 alkyl; and X 8 is —NH— or —N(CH 3 )—. 7. The compound of claim 6 , wherein Y is naphthyl, benzothiazolyl, benzoxazolyl, benzothienyl, quinolinyl, isoquinolinyl, indolizinyl, benzofuranyl or dihydrobenzofuranyl optionally substituted by one or more halogen, alkyl, haloalkyl, alkylthio, haloalkylthio, alkoxy, haloalkoxy, SF 5 , alkylsulfinyl, haloalkylsulfinyl, alkylsulfonyl or haloalkylsulfonyl; and Z is phenyl optionally substituted with one or more halogen, nitro, cyano or CF 3 . 8. The compound of claim 7 , wherein Y is naphthyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, indolizinyl, benzofuranyl or dihydrobenzofuranyl optionally substituted with one or more halogen, haloalkyl, haloalkylthio, SF 5 or haloalkoxy; and Z is phenyl substituted with one or more fluoro, nitro or CF 3 . 9. The compound of claim 7 , wherein Y is naphthyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, indolizinyl, benzofuranyl or dihydrobenzofuranyl optionally substituted with one or more halogen haloalkyl, haloalkoxy, SF 5 or haloalkylthio; and Z is phenyl substituted with one or more fluoro, cyano or CF 3 . 10. The compound of claim 8 , wherein Y is naphthyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl, indolizinyl, benzofuranyl or dihydrobenzofuranyl optionally substituted with one or more halogen, CF 3 , —OCF 3 , —SCF 3 or SF 5 ; and Z is phenyl substituted with nitro and CF 3 . 11. The compound of claim 9 , wherein Y is naphthyl, benzothiazolyl, benzoxazolyl, quinolinyl, isoquinolinyl benzofuranyl or dihydrobenzofuranyl, optionally substituted with one or more halogen, CF 3 , —OCF 3 , —SCF 3 or —SF 5 ; and Z is phenyl substituted with cyano and CF 3 . 12. The compound of claim 8 , wherein: Y is naphthyl, quinolinyl, benzothiazolyl or benzoxazolyl optionally substituted with one or more halogen, or C 1 -C 3 haloalkyl; X 8 is —NH—; R 2 and R 3 are each independently hydrogen or C 1 -C 3 alkyl; Z is phenyl optionally substituted with one or more of F, nitro, cyano or CF 3 ; and n is 2 or 3. 13. The compound of claim 12 , wherein: Y is naphthyl optionally substituted with one or more F, Cl or CF 3 ; R 2 and R 3 are independently hydrogen or CH 3 ; Z is phenyl substituted with one or more nitro, cyano or CF 3 . 14. The compound of claim 12 , wherein: Y is quinolinyl optionally substituted with one or more F, Cl or CF 3 ; R 2 and R 3 are independently hydrogen or CH 3 ; Z is phenyl substituted with one or more nitro, cyano or CF 3 . 15. The compound of claim 12 , wherein: Y is benzothiazole optionally substituted with one or more F, Cl or CF 3 ; R 2 and R 3 are independently hydrogen or CH 3 ; Z is phenyl substituted with one or more nitro, cyano or CF 3 . 16. The compound of claim 12 , wherein: Y is benzoxazole optionally substituted with one or more F, Cl or CF 3 ; R 2 and R 3 are independently hydrogen or CH 3 ; Z is phenyl substituted with one or more nitro, cyano or CF 3 .
Anthelmintics · CPC title
Antiparasitic agents · CPC title
to an acyclic saturated chain · CPC title
2-Quinolinones, e.g. carbostyril · CPC title
acylated on ring nitrogen atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.